# RAB9B

## Overview
RAB9B is a gene that encodes a member of the RAS oncogene family, specifically a small GTPase protein involved in intracellular vesicle trafficking. The RAB9B protein plays a crucial role in the regulation of retrograde transport from late endosomes to the trans-Golgi network, interacting with various proteins such as the BLOC-3 complex and GCC185 to facilitate its function (Kloer2010Assembly; Hayes2009Multiple). As a Golgi-associated Rab protein, RAB9B is integral to vesicle tethering and transport processes within the cell. Its expression and interactions are implicated in several diseases, including colorectal cancer and neurological disorders, highlighting its clinical significance in disease prognosis and potential therapeutic targeting (Jiang2022The; Shang2020Sex).

## Clinical Significance
RAB9B, a member of the RAS oncogene family, is implicated in various diseases through its altered expression and interactions. In colorectal cancer (CRC), RAB9B is significantly downregulated in tumor tissues compared to normal tissues. This downregulation is associated with poor prognostic CRC mesenchymal subtypes (CMS4) and immune-related pathways, suggesting a potential role in predicting prognosis and immunotherapy efficacy (Jiang2022The). Genetic alterations such as mutations and deep deletions in RAB9B may contribute to its downregulation at the transcriptional level in CRC (Jiang2022The).

RAB9B is also involved in autophagy regulation, particularly in vesicle trafficking, and its dysfunction is linked to neurological diseases. Although specific diseases directly caused by RAB9B mutations are not detailed, mutations in RAB proteins generally lead to neurological disorders (Shang2020Sex). Additionally, RAB9B has been identified as a candidate gene related to hemophagocytic lymphohistiocytosis (HLH) through protein-protein interaction network analysis, indicating a potential role in this condition (Bi2022NBAS). The interaction of RAB9B with the biogenesis of lysosome-related organelles complex-3 (BLOC-3) suggests its involvement in lysosomal storage and autophagy processes, which may influence disease progression (Kloer2010Assembly).

## Interactions
RAB9B, a member of the RAS oncogene family, is involved in intracellular vesicle trafficking and interacts with several proteins to facilitate its function. RAB9B interacts with the BLOC-3 complex, which includes the proteins HPS1 and HPS4. This interaction is particularly strong with the GTP-bound active state of Rab9a and Rab9b, indicating a nucleotide-dependent interaction (Kloer2010Assembly). The BLOC-3 complex acts as a Rab9 effector, binding to the switch I and II regions of Rab9a, suggesting a role in the regulation of retrograde transport from late endosomes to the trans-Golgi network (Kloer2010Assembly).

RAB9B also interacts with the GCC185 protein, specifically binding to its C-terminal 110 amino acids. This interaction was confirmed through yeast two-hybrid assays and in vitro binding assays, highlighting RAB9B as one of the Golgi-associated Rabs interacting with GCC185 (Hayes2009Multiple). These interactions are significant for vesicle tethering at the trans-Golgi network, underscoring the role of RAB9B in intracellular transport processes.


## References


[1. (Jiang2022The) Xuefei Jiang, Lanlan Yang, Qianling Gao, Yiting Liu, Xingzhi Feng, Shubiao Ye, and Zihuan Yang. The role of rab gtpases and its potential in predicting immunotherapy response and prognosis in colorectal cancer. Frontiers in Genetics, January 2022. URL: http://dx.doi.org/10.3389/fgene.2022.828373, doi:10.3389/fgene.2022.828373. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.828373)

[2. (Bi2022NBAS) Xiaoman Bi, Qing Zhang, Lei Chen, Dan Liu, Yueying Li, Xiaoxi Zhao, Ya Zhang, Liping Zhang, Jingkun Liu, Chaoyi Wu, Zhigang Li, Yunze Zhao, Honghao Ma, Gang Huang, Xin Liu, Qian-fei Wang, and Rui Zhang. Nbas, a gene involved in cytotoxic degranulation, is recurrently mutated in pediatric hemophagocytic lymphohistiocytosis. Journal of Hematology &amp; Oncology, July 2022. URL: http://dx.doi.org/10.1186/s13045-022-01318-z, doi:10.1186/s13045-022-01318-z. This article has 8 citations.](https://doi.org/10.1186/s13045-022-01318-z)

[3. (Hayes2009Multiple) Garret L. Hayes, Frank C. Brown, Alexander K. Haas, Ryan M. Nottingham, Francis A. Barr, and Suzanne R. Pfeffer. Multiple rab gtpase binding sites in gcc185 suggest a model for vesicle tethering at thetrans-golgi. Molecular Biology of the Cell, 20(1):209–217, January 2009. URL: http://dx.doi.org/10.1091/mbc.E08-07-0740, doi:10.1091/mbc.e08-07-0740. This article has 107 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E08-07-0740)

[4. (Shang2020Sex) Dangtong Shang, Lingling Wang, Daniel J. Klionsky, Hanhua Cheng, and Rongjia Zhou. Sex differences in autophagy-mediated diseases: toward precision medicine. Autophagy, 17(5):1065–1076, April 2020. URL: http://dx.doi.org/10.1080/15548627.2020.1752511, doi:10.1080/15548627.2020.1752511. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2020.1752511)

[5. (Kloer2010Assembly) Daniel P. Kloer, Raul Rojas, Viorica Ivan, Kengo Moriyama, Thijs van Vlijmen, Namita Murthy, Rodolfo Ghirlando, Peter van der Sluijs, James H. Hurley, and Juan S. Bonifacino. Assembly of the biogenesis of lysosome-related organelles complex-3 (bloc-3) and its interaction with rab9. Journal of Biological Chemistry, 285(10):7794–7804, March 2010. URL: http://dx.doi.org/10.1074/jbc.m109.069088, doi:10.1074/jbc.m109.069088. This article has 87 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m109.069088)